|
Causal Medication
|
Trigger
|
Potential ADE
|
| Amikacin |
Serum amikacin greater than 35 mcg/mL |
Toxic amikacin level |
| Antibiotics |
Positive stool cultures for C. diff |
C. difficile infection |
| Antibiotics |
Anti-diarrheals |
C. difficile infection |
| Antibiotics |
Metronidazole (oral) |
C. difficile infection |
| Antibiotics |
Vancomycin (oral) |
C. difficile infection |
| Antibiotics |
Clotrimazole troches |
Thrush |
| Antibiotics |
Nystatin oral suspension |
Thrush |
| Anticholinergic medications, belladonna alkaloids |
Physostigmine |
Anticholineric overdose, belladonna alkaloids overdose |
| Antidepressants, antipsychotics, local anesthetics, etc. |
Phenytoin |
Seizures, arrhythmias |
| Antidepressants, antipsychotics, local anesthetics, etc. |
Lorazepam |
Seizures |
| Antidepressants, antipsychotics, local anesthetics, etc. |
Phenobarbital |
Seizures |
| Antifungals |
Antifungal use and increasing serum creatinine |
Renal insufficiency |
| Anti-hypertensives |
Atropine |
Bradycardia |
| Antipsychotics |
Benztropine |
Extrapyramidal reactions |
| Antipsychotics |
Dantrolene |
Hyperthermia, neuroleptic malignant syndrome |
| Antivirals |
Antifungal use and increasing serum creatinine |
Renal insufficiency |
| Benzodiazepines |
Flumazenil |
Oversedation with benzodiazepine |
| Beta-blockers |
Beta-blocker use and triamcinolone |
Rash |
| Carbamazepine |
Serum carbamazepine greater than 12 mcg/mL |
Toxic carbamazepine level |
| Cyclosporine |
Serum cyclosporine greater than 500 mcg/L |
Toxic cyclosporine level |
| Digoxin |
Serum digoxin level greater than 2 ng/mL |
Toxic digoxin level |
| Digoxin |
Digoxin immune fab (Digibind) |
Toxic digoxin level |
| Digoxin |
Digoxin use and increasing creatinine |
Renal insufficiency |
| Digoxin and amiodarone |
Digoxin and amiodarone use |
Medication interaction leading to digoxin toxicity |
| Dopamine |
Nitroglycerin |
Dopamine extravasation |
| Dopamine |
Phentolamine |
Dopamine extravasation |
| Enoxaparin |
Enoxaparin use and increasing creatinine |
Renal insufficiency |
| Flouroquinolones |
Flouroquinolone use and increasing creatinine |
Renal insufficiency |
| Gentamicin |
Serum gentamicin greater than 10 mg/L |
Toxic gentamicin level |
| Heparin |
Protamine |
Heparin overdose |
| Heparin |
Danaparoid and lepirudin |
Heparin-induced thrombocytopenia |
| Heparin |
PTT greater than 100 seconds |
Excessive anticoagulation with heparin |
| Heparin, ranitidine, NSAIDs, etc. |
Platelet count less than 50,000 |
Drug-induced thrombocytopenia |
| Injectable chemotherapeutic agents |
Dimethyl Sulfoxide (DMSO) |
Chemotherapy extravasation |
| Injectable chemotherapeutic agents |
Hyaluronidase |
Chemotherapy extravasation |
| Insulin, other hypoglycemic agents |
Dextrose 50% in water |
Hypoglycemia |
| Insulin, other hypoglycemic agents |
Glucagon |
Hypoglycemia |
| Insulin, other hypoglycemic agents |
Serum glucose (less than 50) |
Hypoglycemia |
| Lidocaine |
Serum lidocaine greater than 5 mcg/mL |
Toxic lidocaine level |
| Meperidine, other medications |
Diazepam |
Seizures |
| Metformin |
Metformin use and increasing creatinine |
Hepatic insufficiency |
| Miscellaneous |
Hydroxyzine |
Hypersensitivity reaction or drug rash |
| Miscellaneous |
Abrupt stop of a medication order |
ADE |
| Miscellaneous |
Transfer to a higher level of care |
Change in clinical condition |
| Miscellaneous |
Methylprednisolone |
Hypersensitivity reaction |
| Miscellaneous |
Droperidol |
Nausea/emesis |
| Miscellaneous |
Fosphenytoin |
Seizures, arrhythmias |
| Miscellaneous |
Rising serum creatinine |
Renal insufficiency |
| Miscellaneous |
Calamine lotion |
Rash |
| Miscellaneous |
Blood eosinophils greater than 6% |
Eosinophilia related to hypersensitivity reaction |
| Miscellaneous |
Diprolene 0.05% |
Rash |
| Miscellaneous |
Rash |
Hypersenstivity reaction |
| Miscellaneous |
Anti-emetics |
Medication toxicity or overdose |
| Miscellaneous |
Charcoal (activated) |
Medication overdose |
| Miscellaneous |
WBC count less than 3,000 |
Leukopenia related to non-chemotherapy medication6 |
| Miscellaneous |
Antihistamines |
Hypersensitivity reactions, drug rash |
| Miscellaneous |
Diphenhydramine |
Hypersensitivity reactions, drug rash, extrapyramidal reaction |
| Miscellaneous |
Steroids (topical) |
Hypersensitivity reactions, drug rash |
| Miscellaneous |
Steroids (injectable) |
Hypersensitivity reactions |
| Miscellaneous |
Epinephrine |
Hypersensitivity reactions |
| Miscellaneous |
Topical corticosteroids |
Rash |
| Miscellaneous 1 |
Calcium chloride |
Hypocalcemia |
| Miscellaneous 1 |
Calcium gluconate |
Hypocalcemia |
| Miscellaneous 2 |
Hepatotoxic medications and increasing ALT (20%) |
Hepatic insufficiency |
| Miscellaneous 2 |
Serum ALT greater than 150 Units/L |
Hepatic insufficiency |
| Miscellaneous 2 |
Serum bilirubin greater than 10 mg/dL |
Hepatic insufficiency |
| Miscellaneous 2 |
Hepatotoxic medications and increasing AST (20%) |
Hepatic insufficiency |
| Miscellaneous 3 |
Potassium sliding scale and creatinine greater than 2 |
Renal insufficiency |
| Miscellaneous 3 |
Magnesium sliding scale and creatinine greater than 2 |
Renal insufficiency |
| Miscellaneous4 |
Absolute reticulocyte count greater than 2% |
Hemolytic anemia |
| NSAIDs |
Blood transfusions |
NSAID-induced gastric bleeds |
| Opiates |
Naloxone |
Narcotic overdose |
| Opiates |
Combination of 3 or more narcotics ordered |
Opiate-related side effects |
| Opium tincture (mistaken for paregoric) |
Opium tincture deodorized |
Wrong drug error (confusion with paregoric) |
| Phenytoin |
Serum phenytoin levels greater than 20 mcg/mL |
Toxic phenytoin level |
| Potassium, misc. |
Serum potassium greater than 6.5 mmol/L |
Hyperkalemia due to renal insufficiency or drug effect |
| Potassium, misc. |
Sodium polystyrene sulfonate (Kayexalate) |
Hyperkalemia related to renal impairment or drug effect |
| Procainamide |
Serum procainamide greater than 10 mcg/mL |
Toxic procainamide level |
| Quinidine |
Serum quinidine greater than 5 mcg/mL |
Toxic quinidine level |
| Ranitidine |
Ranitidine use and creatinine greater than 2 |
Renal insufficiency |
| Sedatives, analgesics, muscle relaxants |
Patient fall |
ADE related to use of a sedative, analgesic, or muscle relaxant |
| Sedatives, analgesics, neuromuscular blockers |
Intubation or respiratory arrest |
Respiratory depression or aspiration |
| Theophylline |
Serum theophylline greater than 20 mcg/mL |
Toxic theophylline level |
| Tobramycin |
Serum tobramycin greater than 10 mg/L |
Toxic tobramycin level |
| Toxic phenytoin level |
Phenytoin level greater than 18 and albumin less than 3.3 |
Phenytoin overdose |
| Valproic acid |
Serum valproate greater than 120 mcg/mL |
Toxic valproic acid level |
| Vancomycin |
Vancomycin (IV) and increasing creatinine |
Renal insufficiency |
| Vancomycin |
Serum vancomycin greater than 50 mg/L |
Toxic vancomycin level |
| Warfarin |
Phytonadione |
Warfarin overdose |
| Warfarin |
INR greater than 6 |
Excessive anticoagulation with warfarin |